Back
Alkermes PLC Vs. Iterum Therapeutics PLC Industry Stock Comparison
Buy
52
ALKS
Alkermes PLC
Last Price:
24.40
Seasonality Move:
9.19%
Buy
94
ITRM
Iterum Therapeutics PLC
Last Price:
1.56
Seasonality Move:
-17.76%
Buy
52
Alkermes PLC (ALKS)
is a Buy
Is Alkermes PLC a Buy, Sell or Hold?
- The current Alkermes PLC [ALKS] share price is $23.85. The Score for ALKS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- ALKS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
94
Iterum Therapeutics PLC (ITRM)
is a Buy
Is Iterum Therapeutics PLC a Buy, Sell or Hold?
- The current Iterum Therapeutics PLC [ITRM] share price is $1.58. The Score for ITRM is 94, which is 88% above its historic median score of 50, and infers lower risk than normal.
- ITRM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ALKS Stock Price Chart
What is Alkermes PLC's stock price today?
-
The Alkermes PLC share price today is $23.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALKS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITRM Stock Price Chart
What is Iterum Therapeutics PLC's stock price today?
-
The Iterum Therapeutics PLC share price today is $1.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITRM is experiencing slight buying pressure.
ALKS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 35.1 | Sell |
| Chaikin Money Flow: | 861181 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.91 - 26.19) | Sell |
| Bollinger Bands (100): | (25.59 - 29.23) | Sell |
ITRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 50.92 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.49 - 1.69) | Sell |
| Bollinger Bands (100): | (1.43 - 1.83) | Sell |
ALKS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.42 | Sell |
| 20-day SMA: | 24.66 | Sell |
| 50-day SMA: | 26.87 | Sell |
| 200-day SMA: | 27.41 | Sell |
| 8-day EMA: | 24.3 | Sell |
| 20-day EMA: | 24.84 | Sell |
| 50-day EMA: | 26.07 | Sell |
| 200-day EMA: | 27.23 | Sell |
ITRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.58 | Buy |
| 20-day SMA: | 1.58 | Buy |
| 50-day SMA: | 1.53 | Buy |
| 200-day SMA: | 1.31 | Buy |
| 8-day EMA: | 1.57 | Buy |
| 20-day EMA: | 1.57 | Buy |
| 50-day EMA: | 1.57 | Buy |
| 200-day EMA: | 1.49 | Buy |
Alkermes PLC Earnings Growth & ALKS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.15 per share, an increase this year of $1.00 per share, and a decrease next year of $0.09 per share.
Iterum Therapeutics PLC Earnings Growth & ITRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.90 per share, and an increase next year of $0.40 per share.
Alkermes PLC Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Iterum Therapeutics PLC Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||